Credit Suisse Ag Applied Therapeutics Inc. Transaction History

Credit Suisse Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $8,493 - $29,502	-11,175 Reduced 99.92%	9 $0
Q1 2022 May 16, 2022	BUY	$1.48 - $6.22 $1,226 - $5,156	829 Added 8.01%	11,184 $23,000
Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $90,813 - $189,392	10,355 New	10,355 $93,000
Q1 2021 May 14, 2021	SELL	$16.57 - $28.65 $273,239 - $472,438	-16,490 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.44 - $24.23 $87,374 - $137,117	5,659 Added 52.25%	16,490 $363,000
Q3 2020 Nov 13, 2020	BUY	$19.43 - $35.36 $56,871 - $103,498	2,927 Added 37.03%	10,831 $224,000
Q2 2020 Aug 12, 2020	BUY	$29.41 - $51.23 $232,456 - $404,921	7,904 New	7,904 $286,000

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $42.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.